The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized.
Dominant mutations in the tetraspan membrane protein peripheral myelin protein 22 (PMP22) are known to result in peripheral neuropathies such as Charcot-Marie-Tooth type 1A (CMT1A) disease via mechanisms that appear to be closely linked to misfolding of PMP22 in the membrane of the endoplasmic reticulum (ER). To characterize the molecular defects in PMP22, we examined the structure and stability of two human disease mutant forms of PMP22 that are also the basis for mouse models of peripheral neuropathies: G150D ( Trembler phenotype) and L16P ( Trembler-J phenotype). Circular dichroism and NMR spectroscopic studies indicated that, when folded, the three-dimensional structures of these disease-linked mutants are similar to that of the folded wild-type protein. However, the folded forms of the mutants were observed to be destabilized relative to the wild-type protein, with the L16P mutant being particularly unstable. The rate of refolding from an unfolded state was observed to be very slow for the wild-type protein, and no refolding was observed for either mutant. These results lead to the hypothesis that ER quality control recognizes the G150D and L16P mutant forms of PMP22 as defective through mechanisms closely related to their conformational instability and/or slow folding. It was also seen that wild-type PMP22 binds Zn(II) and Cu(II) with micromolar affinity, a property that may be important to the stability and function of this protein. Zn(II) was able to rescue the stability defect of the Tr mutant.
Myers
Jeffrey K
JK
Department of Biochemistry and Center for Structural Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8725, USA.
Mobley
Charles K
CK
Sanders
Charles R
CR
D002413:Cations, Divalent / Q000378:metabolism; D002942:Circular Dichroism; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D009185:Myelin Proteins / Q000737:chemistry* / Q000378:metabolism*; D010523:Peripheral Nervous System Diseases / Q000378:metabolism*; D011485:Protein Binding; D017510:Protein Folding; D013696:Temperature; D015032:Zinc / Q000378:metabolism
D002413:Cations, Divalent; D009185:Myelin Proteins; C073687:PMP22 protein, human; D015032:Zinc
J Nutr. 2000 May;130(5S Suppl):1471S-83S
10801962
Biochim Biophys Acta. 1984 Oct 3;776(2):197-208
6206893
Neurochem Res. 1997 Jul;22(7):811-9
9232633
J Biol Chem. 2002 Sep 13;277(37):34017-23
12107182
Nat Genet. 1995 Nov;11(3):274-80
7581450
Biochemistry. 2007 Oct 2;46(39):11185-95
17824619
Annu Rev Biochem. 2004;73:1019-49
15189166
Biochim Biophys Acta. 2005 Oct 1;1716(1):59-68
16168383
Curr Opin Neurobiol. 2000 Oct;10(5):552-7
11084316
J Mol Biol. 2003 Jul 18;330(4):641-9
12850136
J Neurochem. 2005 Mar;92(6):1531-41
15748170
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14404-9
11717414
J Mol Biol. 2003 Jun 20;329(5):1035-53
12798692
J Neurochem. 1999 Nov;73(5):2110-8
10537071
Biochem J. 2007 Jun 15;404(3):353-63
17521290
J Biomol NMR. 1998 Feb;11(2):233-4
9679300
Neurobiol Dis. 2004 Nov;17(2):300-9
15474367
Chem Rev. 2008 May;108(5):1517-49
18426241
Biochemistry. 2001 Aug 14;40(32):9453-9
11583144
Neurobiol Dis. 1999 Feb;6(1):1-14
10078969
Neurobiol Dis. 1999 Oct;6(5):450-60
10527811
Arch Biochem Biophys. 2008 Jan 1;469(1):46-66
17971290
Chem Rev. 2006 May;106(5):1931-77
16683762
Neurochem Res. 1995 Sep;20(9):1107-13
8570016
Biochemistry. 2001 Jul 31;40(30):8971-80
11467959
Prog Nucleic Acid Res Mol Biol. 2000;64:97-129
10697408
Neurochem Res. 1999 Jun;24(6):723-32
10447455
Brain Res Brain Res Rev. 2001 Oct;36(2-3):213-21
11690618
Biochemistry. 1990 May 1;29(17):4031-7
1694455
Exp Eye Res. 2001 Apr;72(4):363-9
11273664
Neurobiol Dis. 2007 Feb;25(2):252-65
17174099
Glia. 1999 Dec;28(3):256-64
10559784
Annu Rev Biophys Biomol Struct. 2004;33:25-51
15139803
EMBO J. 2008 Jan 23;27(2):315-27
18216874
J Mol Biol. 2008 Apr 25;378(2):337-52
18367207
J Mol Biol. 2004 Dec 3;344(4):1109-21
15544815
Annu Rev Physiol. 2006;68:403-29
16460278
Neurosci Lett. 1987 Dec 16;83(1-2):118-22
3441290
Neurobiol Dis. 2000 Dec;7(6 Pt B):561-73
11114256
Neuroreport. 1998 May 11;9(7):1595-600
9631472
J Neurosci. 1998 Jan 15;18(2):731-40
9425015
J Neurosci. 1997 Oct 15;17(20):7754-62
9315897
Brain Res. 2005 Jun 28;1048(1-2):228-34
15921663
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):483-8
11752407
Trends Biochem Sci. 2004 Dec;29(12):648-55
15544951
J Biol Chem. 2005 Jan 21;280(3):2378-87
15537650
Neurochem Res. 2001 Jun;26(6):599-607
11519720
J Neurosci. 1999 May 1;19(9):3396-403
10212299
Biochemistry. 2004 Jan 13;43(1):19-25
14705927
Cell Mol Life Sci. 2002 Nov;59(11):1851-71
12530518
Proteins. 2004 Mar 1;54(4):648-56
14997561
Biochim Biophys Acta. 2004 Nov 3;1666(1-2):105-17
15519311
Crit Rev Biochem Mol Biol. 2001;36(6):501-603
11798093
J Neurosci. 1999 Mar 15;19(6):2027-36
10066256
Biochemistry. 1997 May 13;36(19):5884-92
9153430
Protein Expr Purif. 2002 Dec;26(3):368-77
12460760
J Neurosci Res. 2000 Oct 1;62(1):15-27
11002284
Neurobiol Dis. 2002 Jul;10(2):109-18
12127149
Physiol Rev. 2007 Oct;87(4):1377-408
17928587
Glia. 2006 Sep;54(4):243-57
16856148
J Neurosci. 2003 Nov 19;23(33):10672-80
14627652
Biochim Biophys Acta. 2004 Nov 3;1666(1-2):250-63
15519319
Curr Opin Cell Biol. 2007 Aug;19(4):359-67
17686625
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9852-7
12119418